NFE2L2 and glioblastoma: Furthermore, our results using U251MG (low levels of NRF2) also demonstrated an interesting scenario of ferroptosis resistance in glioblastoma cells independent of NRF2 expression, in which NRF2 modulation and ferroptosis inhibitors were not sufficient to reverse the cell death caused by ferroptosis inducers.